The objective of this study is to evaluate the strength of the evidence for, and the extent of, overdiagnosis in non-cancer conditions. We systematically searched for studies investigating overdiagnosis in non-cancer conditions. Using the 'Fair Umpire' framework to assess the evidence that cases diagnosed by [...]
Internationally, screening programmes and clinical practice guidelines recommend when older adults should stop cancer screening using upper age limits, but it is unknown how older adults view these recommendations. The obective of this study is to examine older adults’ views and experiences about continuing or [...]
The present study examines the patterns of hospital and emergency department services in conjunction with both pre and post diagnostic periods of CT use, which has not been evaluated to date in adult patients with cancer. The cohort makes use of whole of population data [...]
Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide to undergo regular testing, should be offered testing every 2 years from 50 to 69 years. This [...]
We read the article by Nethery and colleagues with great interest, having noted a similar dramatic increase in the incidence of gestational diabetes in Australia, coincident with widespread adoption of the 1-step test using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. [...]
Our global medical culture has driven excessive diagnostic testing, overmedicalisation, and overtreatment across many conditions that may harm patients, exhaust healthcare resources, and harm the planet. The authors call upon local, national, and international decision makers to more prominently and openly acknowledge these issues and [...]
Overdiagnosis is a concept central to making informed breast cancer screening decisions, and yet when provided information about overdiagnosis, some people are skeptical. This research developed a measure that assessed different ways in which people might express skepticism about overdiagnosis (reactance, self-exemption, disbelief, source derogation [...]
This follow-up study of BreastScreen Victoria’s pilot trial of digital breast tomosynthesis aimed to report interval cancer rates, screening sensitivity, and density-stratified outcomes for tomosynthesis vs mammography screening.
Objectives: To report mastectomy and reoperation rates in women who had breast MRI for screening (S-MRI subgroup) or diagnostic (D-MRI subgroup) purposes, using multivariable analysis for investigating the role of MRI referral/nonreferral and other covariates in driving surgical outcomes.
The impacts of screening asymptomatic, non-cancer health conditions are not universally positive. Limited research exists regarding longer-term impacts. Well-designed, high-quality studies further investigating these impacts are required to assist development of protocols that minimise psychological distress following diagnosis.